Analysts have been eager to weigh in on the Healthcare sector with new ratings on Intuitive Surgical (ISRG – Research Report) and Abbott Laboratories (ABT – Research Report).
Claim 50% Off TipRanks Premium
* Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
* Stay ahead of the market with the latest news and analysis and maximize your portfolio’s potential
Intuitive Surgical (ISRG)
In a report released yesterday, Suraj Kalia from Oppenheimer maintained a Hold rating on Intuitive Surgical. The company’s shares closed last Friday at $523.99.
According to TipRanks.com, Kalia is a 5-star analyst with an average return of 9.3% and a 52.9% success rate. Kalia covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, TriSalus Life Sciences, and Edwards Lifesciences.
Currently, the analyst consensus on Intuitive Surgical is a Strong Buy with an average price target of $650.38, a 22.7% upside from current levels. In a report released yesterday, TipRanks – xAI also downgraded the stock to Hold with a $565.00 price target.
See the top stocks recommended by analysts >>
Abbott Laboratories (ABT)
In a report released yesterday, Danielle Antalffy from UBS maintained a Buy rating on Abbott Laboratories, with a price target of $158.00. The company’s shares closed last Friday at $107.42.
According to TipRanks.com, Antalffy is a 4-star analyst with an average return of 3.4% and a 51.4% success rate. Antalffy covers the Healthcare sector, focusing on stocks such as Treace Medical Concepts, Inspire Medical Systems, and Zimmer Biomet Holdings.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Abbott Laboratories with a $140.35 average price target, a 29.6% upside from current levels. In a report issued on January 9, Bernstein also maintained a Buy rating on the stock with a $154.00 price target.
